Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Levamlodipine/valsartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- 01 Aug 2018 Status changed from recruiting to completed.
- 02 Apr 2013 New trial record
- 29 Mar 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0000710).